Craig-Hallum Maintains Buy on MiMedx Group, Lowers Price Target to $12
Portfolio Pulse from Benzinga Newsdesk
Craig-Hallum analyst Chase Knickerbocker maintains a Buy rating on MiMedx Group (NASDAQ:MDXG) but lowers the price target from $14 to $12.
August 01, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Craig-Hallum analyst Chase Knickerbocker maintains a Buy rating on MiMedx Group but lowers the price target from $14 to $12.
The maintained Buy rating suggests continued confidence in MiMedx Group's prospects, but the lowered price target indicates some tempered expectations. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100